Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Leptin (116-130), amide, mouse: Applied Protocols & Assay Ad
2026-06-03
Leptin (116-130), amide, mouse unlocks precise modeling of energy homeostasis and immune-metabolic crosstalk for obesity and diabetes research. This guide delivers protocol-driven insights, troubleshooting, and advanced applications for leveraging this adipocyte-derived hormone fragment in translational workflows.
-
Deferoxamine Mesylate: Iron-Chelating Agent for Oxidative St
2026-06-03
Deferoxamine mesylate stands out as a versatile iron-chelating agent, enabling precise control of iron-mediated oxidative stress, hypoxia signaling, and tumor growth inhibition in preclinical models. This article details actionable workflows, advanced applications, and troubleshooting strategies that empower researchers to maximize assay reliability and biological insight.
-
Sulfamonomethoxine in Applied Research: Protocols and Optimi
2026-06-02
Sulfamonomethoxine (SMM) stands out as a research-grade veterinary antibiotic for both infection control and environmental fate studies. This article translates cutting-edge findings into actionable workflows, troubleshooting strategies, and comparative insights for scientists in veterinary, aquaculture, and environmental domains.
-
Screening MMV Compounds Against MDR Bacterial and Fungal Iso
2026-06-02
This study systematically evaluated compounds from the MMV Pandemic Response Box for activity against multidrug-resistant (MDR) bacterial and fungal clinical isolates, identifying several agents with potent in vitro efficacy. The findings highlight promising candidates for further research into new antimicrobial strategies targeting challenging pathogens.
-
4-Phenylbutyric Acid: ER Stress Modulation & Research Utilit
2026-06-01
4-Phenylbutyric acid (4-PBA) is a chemical chaperone that alleviates endoplasmic reticulum (ER) stress by promoting proper protein folding. It is widely used to model and mitigate ER stress pathways in apoptosis, autophagic cell death, and disease research. APExBIO’s high-purity 4-PBA (SKU C6831) offers validated performance and critical quality control for advanced cellular stress studies.
-
ML385: NRF2 Inhibitor Unlocks Antioxidant Pathway Research
2026-06-01
ML385, a selective NRF2 inhibitor from APExBIO, is revolutionizing how researchers dissect oxidative stress, cancer resistance, and inflammatory bone disease mechanisms. This article delivers advanced, protocol-driven applications, highlights troubleshooting strategies, and translates fresh insights from recent literature into practical guidance for maximizing ML385's impact in experimental workflows.
-
Foxp1 Inhibits PTH-Driven EndMT to Reduce Valvular Calcifica
2026-05-31
This study demonstrates that endothelial Foxp1 overexpression suppresses Notch pathway activation, inhibiting endothelial-to-mesenchymal transition (EndMT) and attenuating valvular calcification in chronic kidney disease (CKD) models. By clarifying the regulatory interactions between Foxp1, PTH, and the Jagged-1/Notch axis, the research identifies new mechanistic targets for cardiovascular complications in CKD.
-
Targeted CRISPRi Silencing of Fabp4 Reverses Obesity and Liv
2026-05-30
This study demonstrates that nonviral, adipocyte-targeted CRISPR interference against Fabp4 significantly ameliorates obesity, inflammation, hepatic steatosis, and insulin resistance in vivo. The findings establish a platform for precise metabolic disease intervention, with implications for future hepatoprotective and metabolic enzyme modulation research.
-
FITC-Concanavalin A (ConA) Conjugate: Technical Use Guide
2026-05-29
FITC-Concanavalin A (ConA) Conjugate provides a direct, fluorescence-based method for detecting α-D-glucose and α-D-mannose carbohydrates on cell surfaces in immunofluorescence and flow cytometry assays. It is not suitable for non-carbohydrate target detection or for use beyond its defined stability and storage conditions.
-
Spiroplasma eriocheiris Entry: Clathrin-Mediated Endocytosis
2026-05-29
This study reveals that Spiroplasma eriocheiris invades Drosophila S2 cells via clathrin-mediated endocytosis and macropinocytosis, not through caveola-dependent pathways. These mechanistic insights clarify host-pathogen interactions in invertebrate models and offer new directions for cellular infection research.
-
Species-Specific PK of Ester Prodrug HD56: Role of Humanized
2026-05-28
This study demonstrates how humanized liver mice enable accurate in vivo-in vitro correlation for the metabolism of the carboxylic acid ester prodrug HD56, overcoming species-specific differences that limit traditional models. The findings offer a predictive approach for optimizing prodrug pharmacokinetics and streamline early-stage translational drug development.
-
Leptin (116-130), amide, mouse: Translating Endocrine Insigh
2026-05-28
Explore the pleiotropic functions of Leptin (116-130), amide, mouse—a key adipocyte-derived hormone fragment—unveiling its immunometabolic impact and protocol nuances. This article provides advanced assay guidance and bridges endocrine and inflammatory pathways for translational research.
-
Spiroplasma eriocheiris Entry Pathways in Drosophila S2 Cell
2026-05-27
This study provides the first evidence that Spiroplasma eriocheiris invades Drosophila Schneider 2 (S2) cells primarily via clathrin-mediated endocytosis and macropinocytosis, but not through caveola-dependent mechanisms. These mechanistic insights clarify host-pathogen interactions relevant to invertebrate cell infection models and inform the use of endocytic pathway inhibitors in translational research.
-
AG-120 (Ivosidenib): Applied Workflows in AML Mutant IDH1 Re
2026-05-27
AG-120 (Ivosidenib) offers precision targeting of mutant IDH1 to facilitate robust 2-hydroxyglutarate reduction and differentiation in acute myeloid leukemia (AML) models. This guide delivers actionable protocols, troubleshooting strategies, and the latest insights on metabolic dependencies, empowering researchers to optimize mutant IDH1 inhibition workflows.
-
One-step TUNEL Cy3 Apoptosis Detection Kit: Precision TdT La
2026-05-26
The One-step TUNEL Cy3 Apoptosis Detection Kit delivers rapid and sensitive apoptosis detection in tissue sections and cultured cells, supporting translational research from liver transplantation to oncology. Its robust terminal deoxynucleotidyl transferase (TdT) labeling workflow, validated in both animal models and cell cultures, ensures reproducible and quantitative DNA fragmentation analysis.